about
Mammalian target of rapamycin (mTOR) inhibition: potential for antiseizure, antiepileptogenic, and epileptostatic therapy.Update on pregnancy in chronic kidney disease.Impact of mTOR-I on fertility and pregnancy: state of the art and review of the literature.Pregnancy Outcomes Related to Mycophenolate Exposure in Female Kidney Transplant Recipients.The combination of Everolimus with Verapamil reduces ovarian weight and vascular permeability on ovarian hyperstimulation syndrome: a preclinical experimental randomized controlled study.Everolimus, an mTOR pathway inhibitor, is highly successful on ovarian hyperstimulation syndrome by reducing ovarian weight and progesterone levels: a preclinical experimental randomized controlled study.
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
Pregnancy under sirolimus-based immunosuppression.
@en
Pregnancy under sirolimus-based immunosuppression.
@nl
type
label
Pregnancy under sirolimus-based immunosuppression.
@en
Pregnancy under sirolimus-based immunosuppression.
@nl
prefLabel
Pregnancy under sirolimus-based immunosuppression.
@en
Pregnancy under sirolimus-based immunosuppression.
@nl
P2093
P1433
P1476
Pregnancy under sirolimus-based immunosuppression.
@en
P2093
Domingo Casadei
Maria Del C Rial
Olga Guardia
P356
10.1097/01.TP.0000188947.56244.7D
P577
2006-02-01T00:00:00Z